SUSAN HODGES: Open Payments
NPI 1588311732 · HOUSTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 28 payments from 5 companies in 2025. Trend: 2023 $301 · 2024 $738 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $122 |
| Novo Nordisk Inc | 6 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Exact Sciences Corporation | 2 | $35 |
Products named: RINVOQ, AIRSUPRA, CAPLYTA, Ozempic, VRAYLAR, Rybelsus, BREZTRI, The Cologuard Plus Collection Kit.
Industry payments across MS — which companies pay providers there.
